TrialScope is part of Informa Pharma Intelligence, a division of Informa Business Intelligence, Inc. (IBI). IBI is a wholly-owned subsidiary of Informa PLC.

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TrialScope to Address Concern for Clinical Trial Disclosure in Japan


March 25, 2019

Company’s Chief Strategy Officer, Thomas Wicks, to Speak at One Year On: GDPR and Its Implications for Data Disclosure and Data Sharing” Event

JERSEY CITY, NJ, March 25, 2019 – TrialScope, the global leader in clinical trial transparency, compliance and patient engagement solutions, today announced that its Chief Strategy Officer, Thomas Wicks, will speak at the One Year On: GDPR and its Implications for Data Disclosure and Data Sharing event. The meeting, scheduled for May 13, will be hosted by Vivli in Tokyo, and will explore a variety of topics related to clinical trial data, including: clinical trial disclosure, GDPR, data sharing, regulations and more.

“Until now, most of the conversations and regulations regarding trial disclosure have been concentrated in the United States and Europe,” explains Wicks. “We are starting to see this expand rapidly across the globe and I am honored to lead the discussion in Japan as pharmaceutical professionals address these industry issues.”

Wicks’ presentation, “Spotlight on Trial Disclosure Compliance: 2019 Global Regulation Review,” is scheduled for May 13. The session will focus on the growing complexity of global trial disclosure regulations and evolving transparency trends.

“Trial disclosure is a complex process, and only gets more complicated as more countries set their own specific requirements,” continued Wicks. “I am excited to share TrialScope’s expertise regarding disclosure in Japan and other countries around the world.”

Additional speakers at the event will include:

  • Mark Barnes, Partner, JD Ropes and Gray
  • Julie Wood, Director of Strategy and Operations, Vivli

The afternoon session is full, but slots are now open for the just-scheduled morning session. For additional information or to register for the May 13 event, contact TrialScope.

About TrialScope 

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit

About Vivli

Vivli is a nonprofit organization managing a global data-sharing and analytics platform to serve all elements of the international research community. The organization acts as a neutral broker between data contributor and data user and the wider data-sharing community. The ultimate aim of Vivli is to advance human health from the insights and discoveries gained by sharing and analyzing clinical research data. For more information, visit